|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 2625199 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11764764.4 |
| Date of filing the European patent application | 2011-10-07 | |
| (97) | Date of publication of the European application | 2013-08-14 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-22 |
| (46) | Date of publication of the claims translation | 2018-03-12 |
| (86) | Number | PCT/EP2011/067522 |
| Date | 2011-10-07 |
| (87) | Number | WO 2012/045848 |
| Date | 2012-04-12 |
| (30) | Number | Date | Country code |
| 391388 P | 2010-10-08 | US |
| (72) |
GUETTNER, Achim, CH
MACHACEK, Matthias, CH
PAPAVASSILIS, Charis, CH
SANDER, Oliver, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Psoriazės gydymo būdai panaudojant IL-17 antagonistus |
| METHODS OF TREATING PSORIASIS USING IL-17 ANTAGONISTS |
| Payment date | Validity (years) | Amount | |
| 2025-09-19 | 15 | 289.00 EUR |
| 2026-10-07 |